Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
September 2004 Imaging in Neurocysticercosis Sarun Charumilind, Harvard Medical School, Year III Gillian Lieberman, MD Index Patient 2 Index Patient: Mr. CP Mr. CP is a previously healthy 25 y.o. man who immigrated from Cape Verde in 1995 and who presents to an outside hospital with: 5-day history of progressively severe headaches and h/o chronic HA x4 yrs, relieved with change in position 2 days of “forgetfulness” Appearance of agitation and nervousness No significant PMH, allergies, meds. No c/o of N/V, incontinence, visual, speech, personality changes. Given Demerol and Phenergan. CT and MRI with gadolinium are ordered. 3 Index Pt.: Imaging at Outside Hospital Hydrocephalus Third ventricular lesion - ?cyst Transferred to BIDMC Opening pressure > 30 L. frontal ventriculostomy and drain placement Repeat CT/MRI Hydrocephalus of lateral ventricles Third ventricular cyst: coronal cut Third ventricular cyst: transverse cut Third ventricular cyst: sagittal cut Images from PACS, BIDMC 4 Index Pt: BIDMC Imaging: CT & MRI w/ Gad Hydrocephalus of lateral ventricles (CT) Calcification in right pons (CT) 3rd ventricular cyst (MR, post-gad) Calcification in right parietal lobe (CT) Mild, diffusely enlarged ventricles esp. at third ventricule and temporal horns Effaced sulci Scattered calcifications along sulci ( R pons, R post. frontal lobe) Third ventricular cyst with enhancement 5 Images from PACS, BIDMC Differential Diagnosis Obstructive Hydrocephalu s Tumor: benign or malignant Cyst (colloid, arachnoid, PARASITIC) Abscess Congenital Multiple sclerosis Tuberous sclerosis Cyst With Mural Multiple Nodule Intracranial Calcifications Tumor: benign or malignant Atherosclerosis (ganglioglioma, Idiopathic GBM, Physiologic astrocytoma) (dura, choroid Metastasis plexi, pineal gland) PARASITIC cyst (cysticercus, PARASITIC paragonimus) (cysticercosis, paragonimus) Reeder MM and B Felson, Gamuts in Radiology, 2003. 6 Hospital Course & Follow-up SURG: Right transcallosal cyst resection – brown, tan colored cyst removed IMAGING: resolved hydrocephalus W/U: ID consult: PPD neg., no growth in serum or CSF, no AFB, positive Index Pt: Resolution of hydrocephalus (CT) for CC Abs Optho consult: no intraocular Sx Pathology: confirmed NCC TX: Treated with albendazole x 7d + decadron DISCHARGE DX: Neurocysticercosis F/U: headaches resolved, discuss PPX if return to Cape Verde Images from PACS, BIDMC 7 Taenia Solium: Parasite of the Poor Most common helminthic infection of CNS Based on lifecycle, is facilitated only in poor living conditions Endemic to many regions: Mexico, Central and South America, sub-Saharan Africa, Asia Higher prevalence in rural areas (10-25%) High prevalence in high-porkconsuming/-raising countries 50,000 deaths/yr, 20 million infected Most common cause of acquired epilepsy worldwide United States: ~1000 cases per year Global prevalence of Taenia solium ftp://ftp.cdc.gov/pub/infectious_diseases/iceid/2002/pdf/schantz.pdf 8 Taenia Solium: Lifecycle http://www.ucm.es/inf o/parasito/Taenia%20 escolex.jpg 9 http://www.dpd.cdc.gov/dpdx/HTML/Cysticercosis.htm Cysticercosis: Clinical Manifestations Symptomatic Cysticercosis Neurocysticercosis Extraneural Cysticercosis •Eye •Muscle Extraparenchymal Parenchymal •Subcutaneous Pt. #2: Muscular (tongue)* •Intraventricular •Subarachnoid •Spinal Pt. #3: Parenchymal** Pt. #4: Subcutaneous** Pt. #5: Intraocular* 10 Images from *http://www.facmed.unam.mx/grid/photos.htm and **http://faculty.uaeu.ac.ae/~youssefa/homepage/taenia.htm NCC: Pathophysiology Neurocysticercosis 20% Symptomatic 80% Asymptomatic Life Stages of T. Solium Cysticerci •Mass effects •Inflammatory response •Foraminal obstruction •Ventricular obstruction •Asymptomatic •Host immune tolerance •Duration: 3-5 yrs Degree of Sx depends on: •Inflammatory response •Cyst loses ability to moderate immune response •Active NCC •Lifecycle stage •Site •Number of cysts Tx depends on Sx 1. Meds: antiparasitic, antiinflammatory, anticonvulsant 2. Surgery 3. Nothing! Degenerating Inactive •Calcified •Asymptomatic •Potential epileptic/obstructive 11 focus Stage 1: Vesicular Cysts CT: Small, rounded, well-demarcated, low-density w/o edema. Pt. #6: Head CT w/ contrast MRI: signal similar to CSF in T1 and T2; scolex seen in cyst: “hole-with-dot” or “swiss cheese” if severe. Pt. #7: MRI w/o contrast Pt. #8: MRI w/o contrast 122003. Images from Garica HH and Del OH Bruto, Stage 2: Colloidal Cysts Pt. #9: Colloidal cyst on MRI CT: ill-defined with edema, MRI: thick hypointense wall + perilesional hyperintense edema ring pattern with contrast = acute encephalitic phase Pt. #10: Cysticercotic Encephalitis Cysticercotic Encephalitis: diffuse edema + collapsed ventricles + multiple lesions = young cysts attacked by host 13 Images from Garica HH and Del OH Bruto, 2003. Stage 3: Granular Cysts & Stage 4: Calcified Cysts Granular CT: granulomatous Calcified Pt. #11: “Single enhancing lesion” on CT CT: small, hyperdense nodules w/o edema unless relapse Pt. #12: MRI: Signal void w/ surrounding edema Images from Garica HH and Del OH Bruto, 2003. MRI: signal void + hyper- intense edematous rim MRI: edema with high signal surrounding low 14 signal cyst Other Cyst Locations Subarachnoid: large, multi-lobulated Ventricular: best on MRI, isodense on CT Spinal: nonspecific enlargement, filling defects on myelogram Pt. #13: Giant cyst in Sylvian fissure Pt. #14: Ventricular cysts on MRI FLAIR 15 Images from Garica HH and Del OH Bruto, 2003. Comparing Modalities •Plain film: Rarely used (incidental subQ and muscle Ca++) •CT v. MRI: Depends on stage •CT: Cheaper, better at Ca++ •MRI: •Better sensitivity (esp. active cysts, cysts in post. fossa) •Better scolex visualization •Not widely available globally •Approach: CT first, then MRI if inconclusive, strong suspicion, or follow-up. Index Pt: Close-up views of mural nodule cyst: cysticercus with scolex inside (MRI) Images from PACS, BIDMC 16 Other Diagnostic Workup Pt: #15: Taenia solium egg Serology Targets: AntiCC antibodies or cysticercal antigens Substrates: CSF, saliva, or blood Methods: ELISA, complement fixation, immunoblot, etc. Standard: Enzyme-linked immunoblot, detect antiCC Abs http://www.biosci.ohio-state.edu/~parasite/taenia.html Pt. #16: Electron microscopy of an egg Pathology White fluid-filled bladder 5-10 mm diamter w/ solid 2 mm larval tapeworm 17 http://www.facmed.unam.mx/grid/photos.htm Diagnostic Criteria 1. 2. 3. Absolute: Histologic Scolex on imaging Ocular signs Major: Lesions “suggestive” on imaging Positive serology for Abs Improvement after treatment Spontaneous resolution of single lesion Minor: Lesions “compatible” on imaging Clinical signs “suggestive” Positive serology for Abs or Ags CC outside CNS 4. Epidemiologic: Household contact Geographic correlation Travel correlation Diagnosis: Definitive: 1 absolute + 1 epi 2 major + 1 minor + 1 epi Probably: 1 major + 2 minor 1 major + 1 minor + 1 epidemiologic 3 minor + 1 epidemiologic 18 The International Debate over Criteria In the setting of many countries with endemic NCC… • • • • • • • • Biopsy: not possible to perform in all suspected pts. Ocular: direct visualization rare, hardly reported Scolex: uncommon on CT/MRI Epi: majority of Indians have single enhancing, yet this is only a “major” criteria Different DDX: CNS tuberculosis, with also single/multiple tuberculoma that show as multiple enhancing CT/MRI lesions, similar to NCC; also multiple tuberculoma, fungal granuloma, primary or secondary malignancies, and multiple pyogenic abscesses Serology: EITB (Ab immunoblot) not available, not sensitive Tx: albendazole/praziquantel may not be effective, and tx role is unclear “Minor” and “Epi” Criteria: not specific enough? Current criteria more suitable for the patients in regions where both NCC and other CNS infections are uncommon, as opposed to India or other developing countries, which have high prevalence of these. 19 A Patient with MVA 2° to Seizure Mr. EM: previously Pt.#17: Calcification near cranial vertex (CT) healthy 33 yo man from Cape Verde, struck another vehicle at 80 mph. Seized at scene of MVA and outside the ER. Imaging: Trauma, Pt.#17: MR, susceptibility, of same lesion Spine, Head series: No fractures NCHCT: 8 small calcifications without edema TX: Seizure control. No surgery. Pt.#17: T2 MR of same lesion Pt.#17: Cacification in posterior fossa (CT) 20 Images from PACS, BIDMC A Patient with MVA 2° to Seizure (cont.) Remember! In developing regions of the world, seizure is a common first presentation of NCC. NCC is the most common cause of adult-onset acquired epilepsy worldwide. 21 A Patient with Incidental NCC? Mr. RB: 38 yo Nepali man with seizure and head trauma NCHCT: Ventricular and parenchymal calcifications DDX: EtOH withdrawal v. NCC Pt.#18: Multiple parenchymal and ventricular calcifications (noncontrast CT) Images from PACS, BIDMC 22 A Patient with Incidental NCC? (cont.) Remember! Though calcifications may cause obstruction or serve as seizure foci, more often than not, they cause no pathology. 80% of persons with NCC are asymptomatic. 23 A Patient with Arachnoiditis 2° to NCC Mr. MB: 52 yo Cape Verdean man with previous Dx of NCC with 4th ventricular cyst removal Presents: severe HA, fever, and LLE radicular pain, neck stiffness, blurry vision Imaging: Obstructive hydrocephalus + spinal cord inflammation TX: Anti-TB for meningitis without success (misdiagnosis of TB) Pt.#19: Cervicomedullary enhancement (T1 MR) Pt.#19: T1-T2 enhancement (T1 MR) Images from PACS, BIDMC 24 Arachnoiditis 2° to NCC (cont.) Arachnoiditis: spinal cord inflammation evidenced by nerve root clumping and adhesions to thecal sac DX: Hydrocephalus 2° to impaired CSF absorption from CSF inflammatory process Æ Neurocysticercosis Pt.#19: Lumbosacral involvement: clumping and adhesions (T1 MR, post gad) 25 Images from PACS, BIDMC Arachnoiditis 2° to NCC (cont.) Remember! NCC may have spinal manifestations. Despite this patient’s h/o cyst removal, other cysts may have been present in various life stages. Albendazole is only 75-90% effective.* Up to 41% of patients posttreatment may exhibit noninflamed but viable cysts.** *Takayanagui 1992, *Sotelo 1998, **Garcia 2004 26 A Patient with Toxoplasmosis v. NCC Pt.#20: Noncontrast Head CT showing lesions with edema Mr. HD: 33 yo Haitian man who on his 1-year anniversary of being diagnosed with HIV/AIDS presents with severe headaches, photophobia, blurred vision, dizziness, NVx1, neck pain on movement, fevers, chills, sweats Imaging: Multiple enhancing lesions with surrounding edema DX: DISSEMINATED CEREBRAL TOXOPLASMOSIS 27 Images from PACS, BIDMC A Patient with Toxoplasmosis v. NCC (cont.) Remember! The differential for multiple intracranial calcifications is wide. In addition, settings where NCC is highly prevalent are also settings for other infectious pathologies of the brain: toxoplasmosis, lymphoma in HIV patients, TB granulomas, etc. 28 Conclusion Imaging findings depend on modality, cysticercus stage, and location. Both CT and MRI have a role, but CT is the best screening tool. Debatable whether diagnostic criteria work for all global settings (differences in prevalence and technology). Diagnosis often requires serologic, clinical, pathologic, and epidemiologic correlation. 29 References 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. Del Bruto, OH, et al. “Proposed Diagnostic Criteria for Neurocysticercosis.” Neurology. 2001 Jul 24;57(2):177-83. Dunsworth, GA. “Neurocysticercosis: A Review.” Pediatric Nursing. 1999 May 1; 25(3), 301-304. Felson. Gamuts in Radiology. City: Publisher, Year of Publication. A-45 – A118. Garcia HH and OH Del Bruto. “Imaging Findings in Neurocysticercosis.” Acta Tropica. 2003; 87(1), 71-78. Garcia HH et al. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med 2004 Jan 15;350(3):249-58. Jain V, et al. “Disseminated Cysticercosis.” The Journal of the Association of Physicians of India. 2000; 48(1), 1090. Kumar GR. “Diagnositc Criteria for Neurocysticercosis.” Neurology India. 2004; 52(2), 171-177. Leder, K. and P. Weller. “Epidemiology, clinical features, and diagnosis of cysticercosis.” UpToDate Online 12.2, online: http://individual.uptodateonline .com/application/topic.asp?file=parasite/13224. 2004 2 Apr. Nash TE, J Pretell, and HH Garcia. “Calcified Cysticerci Provoke Perilesional Edema and Seizures.” Clinical Infectious Diseases. 2001; 33, 1649-1653. Neelam, P, et al. “Ocular and Orbital Neurocysticercosis.” Acta Ophtalmologica Scandinavica. 2001 Aug; 79(4), 408-413. Ong S, et al. “Neurocysticercosis in Radiographically Imaged Seizure Patients in U.S. Emergency Departments.” Emerging Infectious Diseases. 2002 Jun; 8(6), 608-613. Sotelo J, et al. Short course of albendazole therapy for neurocysticercosis. Arch Neurol 1988 Oct;45(10):1130-3. Takayanagui OM and Jardim E. Therapy for neurocysticercosis. Comparison between albendazole and praziquantel. Arch Neurol 1992 Mar;49(3):290-4. Zimmermann AT and WS Jeffries. “Taenia Solium and Neurocysticercosis.” Medical Journal of Australia. 2001; 175, 670-671. 30 Acknowledgements Joe Barry, MD Steve Reddy, MD Barbara Appignani, MD Andrew Tarulli, MD David Hackney, MD Gillian Lieberman, MD Pamela Lepkowski Larry Barbaras, Webmaster 31